Nanobiotix SA - ADRNBTX
13F holders, Q4 2024 (December 31)18holders +8
8new positions
0sold out
1famous investor
$2.87avg. 13F price*
At the end of Q4 2024, 18 institutions reported holding Nanobiotix SA - ADR (NBTX) in their 13F filings, up 8 from Q3 2024. 8 opened new positions and 0 sold out. The largest holders were Johnson & Johnson ($16.1M), Perceptive Advisors LLC ($764K) and BlackRock, Inc. ($148K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Nanobiotix SA - ADR
- CUSIP
- 63009J107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $333K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 121,725 shares bought and 472,399 shares sold, net −350,674 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Johnson & Johnson | 4.18% | No change | 5,623,816 | $16.1M |
| Perceptive Advisors LLC | 0.02% | Reduce -52.1% | 266,093 | $764K |
| BlackRock, Inc. | 0.00% | Reduce -77.5% | 51,484 | $148K |
| Old Mission Capital LLC | 0.00% | New | 48,474 | $139K |
| Jane Street Group, LLC | 0.00% | New | 23,283 | $73K |
| Millennium Management | 0.00% | New | 13,452 | $39K |
| Goldman Sachs Group Inc. | 0.00% | New | 10,498 | $30K |
| Geode Capital Management, LLC | 0.00% | New | 10,184 | $29K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 7,921 | $23K |
| Morgan Stanley | 0.00% | Add +255000.0% | 5,102 | $15K |
| UBS Group AG | 0.00% | Add +23.1% | 3,817 | $11K |
| Bank of America Corp. | 0.00% | Add +242.3% | 2,417 | $7K |
| JPMorgan Chase & Co. | 0.00% | New | 256 | $735 |
| Citigroup Inc. | 0.00% | Reduce -93.0% | 241 | $692 |
| GAMMA Investing LLC | 0.00% | Reduce -94.6% | 154 | $442 |
| Rhumbline Advisers | 0.00% | No change | 33 | $94 |
| Barclays PLC | 0.00% | Reduce -96.4% | 4 | $11 |
| Royal Bank of Canada | 0.00% | New | 129 | $0 |
"% of holder's portfolio" is NBTX's weight in each manager's 13F, not the share of Nanobiotix SA - ADR the manager owns.